首页|期刊导航|肿瘤学与转化医学(英文)|Comparable outcomes but higher risks of prolonged viral RNA shedding duration and secondary infection in cancer survivors with COVID-19: A multi-center, matched retrospective cohort study
Comparable outcomes but higher risks of prolonged viral RNA shedding duration and secondary infection in cancer survivors with COVID-19: A multi-center, matched retrospective cohort study
Hui Peng Lei Wang Wei Wei Ru Liu Zhen cao Motuma Yigezu Daba Fangfang Wang Bingqing Zhou Hong Qiu Xianglin Yuan Sheng Wang Qi Mei Yuhong Dai Jian Li Ming Li Kathrin Halfter Xueyan Jiang Qin Huang
肿瘤学与转化医学(英文)2020,Vol.6Issue(6):237-246,10.
肿瘤学与转化医学(英文)2020,Vol.6Issue(6):237-246,10.DOI:10.1007/s10330-020-0469-9
Comparable outcomes but higher risks of prolonged viral RNA shedding duration and secondary infection in cancer survivors with COVID-19: A multi-center, matched retrospective cohort study
Comparable outcomes but higher risks of prolonged viral RNA shedding duration and secondary infection in cancer survivors with COVID-19: A multi-center, matched retrospective cohort study
摘要
关键词
COVID-19/SARS-CoV-2/cancer survivor/prognosis/viral shedding/mortalityKey words
COVID-19/SARS-CoV-2/cancer survivor/prognosis/viral shedding/mortality引用本文复制引用
Hui Peng,Lei Wang,Wei Wei,Ru Liu,Zhen cao,Motuma Yigezu Daba,Fangfang Wang,Bingqing Zhou,Hong Qiu,Xianglin Yuan,Sheng Wang,Qi Mei,Yuhong Dai,Jian Li,Ming Li,Kathrin Halfter,Xueyan Jiang,Qin Huang..Comparable outcomes but higher risks of prolonged viral RNA shedding duration and secondary infection in cancer survivors with COVID-19: A multi-center, matched retrospective cohort study[J].肿瘤学与转化医学(英文),2020,6(6):237-246,10.基金项目
Supported by grants from the SGC's Rapid Response Funding for Bilgateral Collaborative Emergence COVID-19 Project between China and Germany (No. C-0065), COVID-19 Emergency Project of Huazhong University of Science and Technology (No. 2020kfyXG-YJ062), and Hepatobiliary and Pancreatic Cancer Grant, Hubei Chen Xiaoping Science and Technology Development Foundation (No. CXPJJH12000001-2020344). (No. C-0065)